Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biruh Workeneh

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Kidney & Blood Pressure Research|March 12, 2024
Pitfalls of Current Diagnostic Criteria of Tumor Lysis SyndromeNaji Alhamid, Bana Sabbagh, Asmaa Alsarraj, et al.
Stem Cells Translational Medicine|December 22, 2022
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy)Michael H Carstens, Nelson García, Sreedhar Mandayam, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 18, 2020
Healthy Eating Index of Living Donor Renal Transplantation Recipients During the First Year PosttransplantNhi Le, Linda W Moore, Joy V Nolte Fong, et al.
Kidney International|May 14, 2010
Effects of aging on glomerular function and number in living kidney donorsJane C Tan, Stephan Busque, Biruh Workeneh, et al.
Kidney International Reports|May 25, 2026
Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes MellitusJuan J Cintrón-García, Maulinkumar Patel, Clark R Andersen, et al.
Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
Lancet (London, England)|January 30, 2026
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198Howard Trachtman, Matthias Kretzler, Loreto Gesualdo, et al.
The New England Journal of Medicine|March 6, 2026
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus ErythematosusRichard A Furie, Maria Dall'Era, Edward M Vital, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Kidney & Blood Pressure Research|March 12, 2024
Pitfalls of Current Diagnostic Criteria of Tumor Lysis SyndromeNaji Alhamid, Bana Sabbagh, Asmaa Alsarraj, et al.
Stem Cells Translational Medicine|December 22, 2022
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy)Michael H Carstens, Nelson García, Sreedhar Mandayam, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 18, 2020
Healthy Eating Index of Living Donor Renal Transplantation Recipients During the First Year PosttransplantNhi Le, Linda W Moore, Joy V Nolte Fong, et al.
Kidney International|May 14, 2010
Effects of aging on glomerular function and number in living kidney donorsJane C Tan, Stephan Busque, Biruh Workeneh, et al.
Kidney International Reports|May 25, 2026
Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes MellitusJuan J Cintrón-García, Maulinkumar Patel, Clark R Andersen, et al.
Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
Lancet (London, England)|January 30, 2026
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198Howard Trachtman, Matthias Kretzler, Loreto Gesualdo, et al.
The New England Journal of Medicine|March 6, 2026
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus ErythematosusRichard A Furie, Maria Dall'Era, Edward M Vital, et al.
Pageof 3